Company News »

Transgenomic to Present at Rodman & Renshaw 16th Annual Global Investment Conference

Business Wire
Share on StockTwits
Published on

Transgenomic, Inc. (NASDAQ:TBIO) , a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced that senior management will give a corporate presentation at the Rodman & Renshaw 16th Annual Global Investment Conference being held at the New York Palace Hotel in New York City. Transgenomic will present on Wednesday, September 10, 2014 at 11:15 am ET. Transgenomic Chief Executive Officer Paul Kinnon and Chief Financial Officer Mark Colonnese will participate.

For more information about the Rodman & Renshaw Global Investment Conference, click here.

About Transgenomic
Transgenomic, Inc. is a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic technologies, such as its revolutionary ICE COLD-PCRTM and its unique genetic tests provided through its Patient Testing business. The company also provides specialized clinical and research services to biopharmaceutical companies developing targeted therapies and sells equipment, reagents and other consumables for applications in molecular testing and cytogenetics. Transgenomic’s diagnostic technologies are designed to improve medical diagnoses and patient outcomes.

Share on StockTwits